Table 4

Incidence of AEs

PF-00547659
Placebo (n=63)22.5 mg (n=66)75 mg (n=65)225 mg (n=68)
Number of AEs141175192190
Patients with AEs, n (%)54 (85.7)57 (86.4)51 (78.5)54 (79.4)
Patients with SAEs, (%)5 (7.9)11 (16.7)9 (13.8)11 (16.2)
Patients who discontinued due to AEs, n (%)3 (4.8)9 (13.6)8 (12.3)4 (5.9)
Patients with dose reduction or temporary discontinuation due to AEs, n (%)02 (3.0)3 (4.6)2 (2.9)
  • AE, adverse event; SAE, serious adverse event.